NH
NATIONAL HEALTH INVESTORS INC (NHI)·Q2 2025 Earnings Summary
Executive Summary
- Q2 2025 was stronger than expected with higher rental income and SHOP performance; diluted EPS was $0.79, NAREIT FFO/share $1.19, Normalized FFO/share $1.22, and Normalized FAD $56.0M .
- NHI raised full-year 2025 Normalized FFO guidance to $4.78–$4.82 and Normalized FAD to $227.9–$229.8M, while lowering NAREIT FFO to $4.46–$4.50; the Board also approved a dividend increase to $0.92/share (first since 2021) .
- The company transitioned seven properties from leases to SHOP effective August 1, adding ~$8.8M annualized SHOP NOI with expected double-digit growth in 2026; liquidity is strong at ~$760M with net debt/adjusted EBITDA at 3.9x .
- Versus S&P Global consensus, Q2 revenue and EPS were beats; improved visibility and record SHOP NOI margin (26.9%) highlight a durable growth narrative and catalysts into H2 (acquisitions, SHOP scaling, dividend increase) .
What Went Well and What Went Wrong
What Went Well
- Record SHOP metrics: SHOP NOI +29.4% YoY to $3.8M; RevPOR +3.7% YoY; SHOP NOI margin reached a record 26.9% since SHOP’s formation. “RevPAR growth of 3.7% and NOI margin at 26.9% are both record results…” .
- Guidance and dividend actions: Normalized FFO raised again (midpoint +$0.09), Normalized FAD raised, and dividend increased to $0.92/share, signaling confidence and coverage strength .
- External growth momentum: $63.5M memory care acquisition, $28.0M construction loan at 9%, and ~$129.9M signed LOIs (avg 8% yield) with a broader ~$343.0M pipeline focused on senior housing/S HOP .
What Went Wrong
- Lowered NAREIT FFO guidance to $4.46–$4.50 (from $4.64–$4.70), reflecting conversion and accounting impacts (straight-line rent write-off) even as Normalized FFO rose .
- SHOP occupancy softness post-Q2 due to localized leadership changes and abnormal move-outs; management expects normalization but implied slower H2 growth within a 13–16% same-store SHOP NOI range .
- Higher operating costs: Legal expenses +$0.9M and G&A +$1.3M YoY tied to SHOP transition and compensation; proxy-related costs affected reported results .
Financial Results
Reported Results vs Prior Periods
Actual vs S&P Global Consensus
Estimates marked with * are values retrieved from S&P Global.
S&P Global estimates detail: EPS estimate count Q2 2025: 5; Revenue estimate count Q2 2025: 6.*
Segment NOI Breakdown
KPIs (SHOP)
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “We followed a strong start to the year with an even stronger quarter… Due to the outperformance and good visibility, we're raising our 2025 guidance for the second time this year.” — Eric Mendelsohn, CEO .
- “RevPAR growth of 3.7% and NOI margin at 26.9% are both record results since SHOP's formation.” — Eric Mendelsohn, CEO .
- “Our net debt to adjusted EBITDA at 3.9 times… and we have available liquidity of approximately $760,000,000.” — Eric Mendelsohn, CEO .
- “Our Board… declared a $0.92 per share dividend… and we adjusted our full year 2025 guidance… Normalized FFO at the midpoint is $4.8 or an increase of 8.1%.” — John Spaid, CFO .
Q&A Highlights
- Pipeline timing: Closings delayed by conversion focus, but robust LOIs expected to close soon; management views delays as timing, not disruption .
- Funding approach: Aim for leverage-neutral, but pivoted to more equity when cost of equity approximated long-term debt; flexibility remains .
- Discovery relationship: Still an ongoing partner with 10 SHOP buildings; transitioned smaller/secondary-market assets to a new operator better suited to drive growth .
- SHOP occupancy softness: Attributed to local leadership transitions and abnormal move-outs; flows of move-ins stable; expected normalization .
- NHC renegotiation: Special Board Committee actively engaged; enterprise coverage improved to ~4.16x; potential portfolio culling and higher rent on remaining assets contemplated .
Estimates Context
- Q2 2025 results beat consensus: Revenue $90.662M vs $86.162M estimate (beat ~$$4.50M); diluted EPS $0.79 vs $0.757 estimate (beat ~$$0.03). EBITDA modestly above consensus (actual* $72.806M vs estimate* $71.086M) — a supportive backdrop for guidance raises *.
- Estimate counts: EPS (5), Revenue (6) in Q2 2025.*
- Following raised Normalized FFO/FAD, and the SHOP transition (normalized adjustments), Street models likely need upward revisions to Normalized FFO/FAD; GAAP/NAREIT FFO may see transient Q3 volatility from the straight-line lease write-off .
Estimates marked with * are values retrieved from S&P Global.
Key Takeaways for Investors
- The beat on revenue and EPS, combined with raised Normalized FFO/FAD and a dividend increase, strengthens near-term sentiment; watch for additional SHOP acquisitions as incremental catalysts .
- SHOP operating momentum is tangible (record margin, RevPOR growth); short-term occupancy softness appears idiosyncratic and being addressed, but it tempers H2 growth pacing in guidance .
- Expect Q3 reported NAREIT FFO impact from ~$12.1M straight-line rent write-off tied to Discovery lease termination; normalized metrics adjust these effects, keeping core performance intact .
- Balance sheet optionality is high (3.9x net debt/EBITDA; ~$760M liquidity), enabling accretive external growth while maintaining flexibility on funding mix .
- Tenant fundamentals: Bickford coverage/occupancy improving; continued deferral repayments provide base rent capture opportunity and reduce variability over time .
- Governance uptick and active engagement on NHC renegotiation (with strong enterprise coverage) could unlock value through portfolio optimization and rent resets .
- Trading lens: Near-term tailwinds from dividend raise and guidance increase; monitor execution on signed LOIs/SHOP scaling and Q3 accounting impacts to NAREIT FFO to avoid misinterpretation of underlying strength .